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We report 4 patients with retinal hemorrhages that
developed during hospitalization for dengue fever. Onset of
symptoms coincided with resolution of fever and the nadir
of thrombocytopenia. Retinal hemorrhages may reflect the
rising incidence of dengue in Singapore or may be caused
by changes in the predominant serotype of the dengue
virus. 
D
engue is usually a self-limiting viral fever spread by
the Aedes aegypti mosquito. Minor bleeding frequent-
ly complicates dengue fever. Hemorrhagic complications
are usually mild and limited to gum bleeding, epistaxis,
hematuria, or menorrhagia (1). However, cases of severe
and life-threatening bleeding have been reported in the
medical literature. Rarely, retinal hemorrhages affecting
patients with dengue fever are reported. We report 4
patients with dengue fever complicated by retinal hemor-
rhages who were hospitalized in our institution in June and
July 2004.
The Study
In June and July 2004, a total of 1,620 cases of dengue
fever and dengue hemorrhagic fever were reported in
Singapore; 621 case-patients were admitted to our hospi-
tal. In the same period, retinal hemorrhages were diag-
nosed in 4 dengue fever patients in our hospital. 
As part of our protocol, we use polymerase chain reac-
tion (PCR) (while a patient is still febrile) and serology
(after resolution of fever) to confirm clinical diagnoses of
dengue fever. Real time-PCR is performed daily with com-
mercial reagents (Artus GmbH, Hamburg, Germany) on a
Light Cycler (Roche Diagnostics, Penzberg, Germany).
Serology is performed with the Dengue Duo IgM and IgG
Rapid Strip Test (PanBio, Brisbane, Queensland,
Australia). Dengue serotypes were determined by
immunofluorescence, with type-specific monoclonal anti-
bodies, on virus cultured from serum taken early in the dis-
ease. The diagnosis of retinal hemorrhage was made by an
ophthalmologist after dilated fundoscopic examination.
Fundal photography was also performed for all patients for
baseline recording. 
Four patients (3 women and l man) had visual symp-
toms, which developed during hospitalization for dengue
fever. The mean age of the patients was 34 years (range
21–49). Four patients had reduced visual acuity. Two
patients noticed the visual problems in the morning upon
waking up. One patient complained of metamorphopsia.
All denied any associated eye pain, photophobia, or
increased tearing. Except mild myopia in 1 patient, no
patient had a history of medical or ocular problems. The
average duration of fever before visual symptoms devel-
oped was 6.25 days (range 5–8). The onset of visual symp-
toms was usually observed within 1 day from the
resolution of fever and the nadir of the thrombocytopenia.
The average platelet count on the day of onset of symp-
toms was 36 × 109/L (range 33–44). The lowest platelet
count was recorded 1 day before the onset of symptoms in
1 patient, on the day of onset of symptoms in 2 patients,
and 1 day after the onset of symptoms in 1 patient. The
average platelet count at the nadir of thrombocytopenia
was 33 × 109/L (range 26–40). 
Fundoscopic examination showed bilateral blot hemor-
rhages within the vascular arcades in all 4 patients. All
patients received standard supportive care, and 2 patients
received platelet transfusion. 
The clinical diagnosis of dengue fever was confirmed
by PCR in 2 cases, by immunoglobulin (Ig)G and IgM in
1 patient, and by IgM in the remaining patient. Dengue
virus was isolated from all 4 patients. All were serotype 1.
In 3 patients, visual symptoms resolved completely within
2 days, with full recovery of the patients’ visual acuities.
Improvement in visual symptoms was delayed and incom-
plete in patient 4, and she had reduced visual acuity and
metamorphopsia even after 2 months.
Conclusions
Singapore has experienced a steady rise in the inci-
dence of dengue in recent years. In 2002, a total of 3,937
cases of dengue were reported, followed by 4,785 cases in
2003. As of September 11, 2004, a total of 4,985 cases
were reported (2). 
Hemorrhagic diathesis is a common complication of
dengue fever. Such complications typically occur toward
the end of the febrile period, when the symptoms of clas-
sic dengue fever resolve. Clinically, bleeding is usually
mild and manifests itself as epistaxis, gum bleeding, hema-
turia, and menorrhagia. Only occasional cases of severe
gastrointestinal or retroperitoneal bleeding are reported.
However, retinal hemorrhages are exceedingly rare as a
complication of dengue fever. 
We performed a Medline search using dengue and reti-
nal hemorrhage as key words. It showed only 4 case
reports describing retinal hemorrhages associated with
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*Tan Tock Seng Hospital, Singaporedengue fever (3–6). Only 1 case was reported in the
English medical literature. Haritoglou et al. (3) described a
patient with dengue fever who had bilateral loss of vision.
Fundoscopic examination indicated exudative maculopa-
thy and small hemorrhages located in the nerve fiber layer.
Initially, this patient had a visual acuity of 20/250 in both
eyes. It increased to 20/100 in the right eye and 20/32 in
the left eye 8 weeks after the patient was initially seen. The
residual deficit was assumed to be due to intraretinal lipid
deposits. Wen et al. (4) described 24 patients with visual
disturbances complicating dengue fever. The mean age of
these patients was 32 (range 16–45); 19 of them had blur-
ring of vision, while others complained of central scotoma,
floaters, photophobia, or halo vision. Five patients report-
ed unilateral symptoms. Visual symptoms developed in
most patients 5–8 days (range 2–15) after the onset of
fever. Fundoscopic examination indicated retinal hemor-
rhages in 15 patients. Seven of the remaining 9 patients
were seen a long time after the onset of symptoms, and
fundoscopic examination showed only mild, atypical mac-
ulopathy. Optic nerve atrophy developed in 1 patient, and
another patient was diagnosed with optic neuritis. 
Our observations are similar to those described in the
above reports. Our patients were also young, and visual
symptoms developed 5–8 days after the onset of fever,
consistent with current theories on the immunopathogene-
sis of dengue (7). All our patients complained of decreased
visual acuity, and fundoscopic examination showed macu-
lar hemorrhages and exudative maculopathy. Careful
review of clinical records allowed us to make additional
observations, which have not been previously reported. In
all our patients, visual symptoms developed shortly (with-
in 1 day) before or after resolution of fever. The onset of
symptoms was also associated with the nadir of thrombo-
cytopenia. 
All patients were evaluated by an ophthalmologist.
They were treated conservatively, and 2 received platelet
transfusion. Although 3 patients improved symptomatical-
ly within 2 days, recovery was slower and incomplete in
the fourth patient. Although we see a considerable number
of patients with dengue in our hospital, these patients are
the first we have seen with dengue fever complicated by
retinal hemorrhages. We postulate 2 explanations for this
new clinical manifestation. First, the recent, sharp rise in
the incidence of dengue fever may have allowed us to
observe this otherwise rare manifestation. Or, their infec-
tion could have been caused by a particularly virulent type
of dengue virus.
We cultured virus from acute-phase serum samples
from all 4 patients; all were serotype 1. In 2003, 72% of 68
viruses isolated from sequential sera were serotype 2, and
21% were serotype 1. This proportion has changed dramat-
ically over the last year. In 2004, 70% of 37 sequential
isolates belonged to serotype 1 and only 22% to serotype 2
(Barkham T., unpub. data). Although it is tempting to pre-
sume that the recent increase in incidence of retinal hem-
orrhages is associated with the unique virulence of
serotype 1 virus, the fact that the dengue virus in all 4
patients belonged to serotype 1 may have been pure chance
and merely reflect the fact that serotype 1 became predom-
inant in 2004. We are planning to clarify this issue by con-
ducting a prospective study and would be pleased to hear
from other centers with similar experiences. 
Only a small minority of patients admitted with dengue
fever reported ocular symptoms. All of them had retinal
hemorrhages involving the macula. Hemorrhage involving
peripheral parts of the retina is probably much more com-
mon. However, such patients may remain asymptomatic or
have only minimal symptoms. The true incidence of reti-
nal hemorrhage in dengue fever may be substantially high-
er. Further studies will be necessary to determine the true
incidence of retinal hemorrhage in patients with dengue
fever.
Retinal hemorrhage is a rare but potentially serious
complication of dengue fever. The onset of symptoms
appears to coincide with the resolution of fever and the
nadir of thrombocytopenia. Patients with dengue fever
who report visual symptoms should be evaluated prompt-
ly. Although there is no specific therapy, retinal hemor-
rhage may be an indication for early and aggressive
correction of thrombocytopenia.
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